DE602004017777D1 - Tricyclische indolhydroxyethylaminderivate und deren verwendung bei der behandlung von alzheimer-krankheit - Google Patents
Tricyclische indolhydroxyethylaminderivate und deren verwendung bei der behandlung von alzheimer-krankheitInfo
- Publication number
- DE602004017777D1 DE602004017777D1 DE602004017777T DE602004017777T DE602004017777D1 DE 602004017777 D1 DE602004017777 D1 DE 602004017777D1 DE 602004017777 T DE602004017777 T DE 602004017777T DE 602004017777 T DE602004017777 T DE 602004017777T DE 602004017777 D1 DE602004017777 D1 DE 602004017777D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- indolhydroxyethylamine
- tricyclic
- derivatives
- alzheimer disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0328900.6A GB0328900D0 (en) | 2003-12-12 | 2003-12-12 | Novel compounds |
PCT/EP2004/014076 WO2005058915A1 (en) | 2003-12-12 | 2004-12-09 | Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004017777D1 true DE602004017777D1 (de) | 2008-12-24 |
Family
ID=30130158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004017777T Expired - Fee Related DE602004017777D1 (de) | 2003-12-12 | 2004-12-09 | Tricyclische indolhydroxyethylaminderivate und deren verwendung bei der behandlung von alzheimer-krankheit |
Country Status (17)
Country | Link |
---|---|
US (1) | US20070073060A1 (de) |
EP (1) | EP1692143B1 (de) |
JP (1) | JP2007513913A (de) |
KR (1) | KR20060121164A (de) |
CN (1) | CN1914214A (de) |
AT (1) | ATE414090T1 (de) |
AU (1) | AU2004299231A1 (de) |
BR (1) | BRPI0417476A (de) |
CA (1) | CA2549072A1 (de) |
DE (1) | DE602004017777D1 (de) |
GB (1) | GB0328900D0 (de) |
IL (1) | IL175819A0 (de) |
IS (1) | IS8521A (de) |
MA (1) | MA28241A1 (de) |
NO (1) | NO20063137L (de) |
RU (1) | RU2006124863A (de) |
WO (1) | WO2005058915A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007528400A (ja) | 2004-03-09 | 2007-10-11 | エラン ファーマシューティカルズ,インコーポレイテッド | 置換ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬 |
WO2006010095A2 (en) | 2004-07-09 | 2006-01-26 | Elan Pharmaceuticals Inc. | Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
MX2007003281A (es) * | 2004-09-21 | 2007-05-18 | Pfizer Prod Inc | N-etilhidroxietilamina util en el tratamiento de afecciones del sistema nervioso central. |
GB0422766D0 (en) * | 2004-10-13 | 2004-11-17 | Glaxo Group Ltd | Novel compounds |
GB0422765D0 (en) * | 2004-10-13 | 2004-11-17 | Glaxo Group Ltd | Novel compounds |
WO2007047305A1 (en) | 2005-10-12 | 2007-04-26 | Elan Pharmaceuticals, Inc. | Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
US7838676B2 (en) | 2005-11-21 | 2010-11-23 | Amgen Inc. | Beta-secretase modulators and methods of use |
US7872009B2 (en) | 2005-11-21 | 2011-01-18 | Amgen Inc. | Beta-Secretase modulators and methods of use |
FR2919288B1 (fr) * | 2007-07-27 | 2009-09-04 | Sanofi Aventis Sa | Derives de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6- carboxamides, leur preparation et leur application en therapeutique. |
FR2919285B1 (fr) | 2007-07-27 | 2012-08-31 | Sanofi Aventis | Derives de 1-oxo-isoindoline-4-carboxamides et de 1-oxo- 1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur preparation et leur application en therapeutique. |
FR2919286A1 (fr) | 2007-07-27 | 2009-01-30 | Sanofi Aventis Sa | Derives de derives de 1-oxo-1,2-dihydroisoquinoleine-5- carboxamides et de 4-oxo-3,4-dihydroquinazoline-8- carboxamides,leur preparation et leur application en therapeutique. |
AU2008306835A1 (en) * | 2007-07-27 | 2009-04-09 | Sanofi-Aventis | 1,2,3,4-tetrahydropyrrolo[1,2-A]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-A][1,4]-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof |
FR2919289B1 (fr) * | 2007-07-27 | 2009-09-04 | Sanofi Aventis Sa | Derives de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]- diazepine-7-carboxamides, leur preparation et leur application en therapeutique. |
MX2010012807A (es) * | 2008-05-29 | 2010-12-21 | Albany Molecular Res Inc | Moduladores del rceptor 5-hidroxitriptamina 3, metodos de fabricacion y uso de los mismos. |
FR2960876B1 (fr) | 2010-06-03 | 2012-07-27 | Sanofi Aventis | Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique. |
CN103096893B (zh) | 2010-06-04 | 2016-05-04 | 阿尔巴尼分子研究公司 | 甘氨酸转运体-1抑制剂、其制备方法及其用途 |
MX365851B (es) * | 2012-08-24 | 2019-06-17 | Treventis Corp | Compuestos de benzofurazano anti-amiloides y metodos. |
WO2019075358A1 (en) * | 2017-10-13 | 2019-04-18 | Ghosh Arun K | BACE1 INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69828682T2 (de) * | 1997-02-04 | 2006-04-06 | The Regents Of The University Of California, Oakland | Nanomolare, non-peptidische inhibitoren von cathepsin d |
US6207664B1 (en) * | 1998-11-25 | 2001-03-27 | Pfizer Inc. | Squalene synthetase inhibitor agents |
US7119085B2 (en) * | 2000-03-23 | 2006-10-10 | Elan Pharmaceuticals, Inc. | Methods to treat alzheimer's disease |
CA2410680A1 (en) * | 2000-06-30 | 2002-01-10 | Elan Pharmaceuticals, Inc. | Compounds to treat alzheimer's disease |
AP2004003049A0 (en) * | 2001-11-08 | 2004-06-30 | Elan Pharm Inc | N,N' -substituted-1,3-diamino -2-hydroxypropane derivatives. |
GB0228410D0 (en) * | 2002-12-05 | 2003-01-08 | Glaxo Group Ltd | Novel Compounds |
GB0309221D0 (en) * | 2003-04-23 | 2003-06-04 | Glaxo Group Ltd | Novel compounds |
-
2003
- 2003-12-12 GB GBGB0328900.6A patent/GB0328900D0/en not_active Ceased
-
2004
- 2004-12-09 AT AT04803724T patent/ATE414090T1/de not_active IP Right Cessation
- 2004-12-09 RU RU2006124863/04A patent/RU2006124863A/ru not_active Application Discontinuation
- 2004-12-09 CN CNA2004800416435A patent/CN1914214A/zh active Pending
- 2004-12-09 WO PCT/EP2004/014076 patent/WO2005058915A1/en active Application Filing
- 2004-12-09 AU AU2004299231A patent/AU2004299231A1/en not_active Abandoned
- 2004-12-09 EP EP04803724A patent/EP1692143B1/de active Active
- 2004-12-09 CA CA002549072A patent/CA2549072A1/en not_active Abandoned
- 2004-12-09 BR BRPI0417476-3A patent/BRPI0417476A/pt not_active IP Right Cessation
- 2004-12-09 DE DE602004017777T patent/DE602004017777D1/de not_active Expired - Fee Related
- 2004-12-09 US US10/596,296 patent/US20070073060A1/en not_active Abandoned
- 2004-12-09 KR KR1020067011376A patent/KR20060121164A/ko not_active Application Discontinuation
- 2004-12-09 JP JP2006543488A patent/JP2007513913A/ja not_active Withdrawn
-
2006
- 2006-05-22 IL IL175819A patent/IL175819A0/en unknown
- 2006-06-26 IS IS8521A patent/IS8521A/xx unknown
- 2006-06-26 MA MA29143A patent/MA28241A1/fr unknown
- 2006-07-06 NO NO20063137A patent/NO20063137L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2005058915A1 (en) | 2005-06-30 |
GB0328900D0 (en) | 2004-01-14 |
IL175819A0 (en) | 2006-10-05 |
KR20060121164A (ko) | 2006-11-28 |
MA28241A1 (fr) | 2006-10-02 |
AU2004299231A1 (en) | 2005-06-30 |
CA2549072A1 (en) | 2005-06-30 |
ATE414090T1 (de) | 2008-11-15 |
US20070073060A1 (en) | 2007-03-29 |
IS8521A (is) | 2006-06-26 |
EP1692143A1 (de) | 2006-08-23 |
JP2007513913A (ja) | 2007-05-31 |
EP1692143B1 (de) | 2008-11-12 |
NO20063137L (no) | 2006-08-31 |
BRPI0417476A (pt) | 2007-05-08 |
RU2006124863A (ru) | 2008-01-20 |
CN1914214A (zh) | 2007-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7925A (is) | Hýdroxýetýlamínafleiður til að meðhöndla Alzheimers-sjúkdóm | |
IL175819A0 (en) | Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease | |
ATE396174T1 (de) | Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten | |
WO2004080376A3 (en) | Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer’s disease | |
ATE396973T1 (de) | Benzylether- und benzylamino-beta-sekretase- hemmer zur behandlung von alzheimer-krankheit | |
CY1111086T1 (el) | Παραγωγα 2-αμινο-κιναζολινης χρησιμα ως αναστολεις της βητα-σεκρετασης (bace) | |
EA200600294A1 (ru) | [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении | |
ATE506951T1 (de) | Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit | |
ATE517861T1 (de) | Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
WO2005090296A3 (en) | N-substituted benzene sulfonamides | |
ATE527261T1 (de) | 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten | |
BRPI0409622A (pt) | derivados tricìclicos de indol e o seu uso no tratamento da doença de alzheimer | |
ATE512147T1 (de) | Makrozyklische aminiopyridyl-beta-sekretase- hemmer zur behandlung von morbus alzheimer | |
ATE519740T1 (de) | Tetrahydroindolderivate zur behandlung von alzheimer-krankheit | |
ATE425967T1 (de) | Piperazin und piperadin-derivate fur die behandlung von neurologischen krankheiten | |
ATE469146T1 (de) | Benzofuranderivate und deren verwendung bei der behandlung von mikrobiellen infektionen | |
ATE263139T1 (de) | 3-alkoxylbenzylaminderivate und ihre verwendung als arzneimittel zur behandlung von schizophrenie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |